We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-14.68%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$30.2B
AUM Growth
-$16.4B
Cap. Flow
-$9.03B
Cap. Flow %
-29.95%
Top 10 Hldgs %
24.78%
Holding
2,286
New
90
Increased
145
Reduced
1,551
Closed
496

Top Buys

Rank Stock Value
1
PNR icon
Pentair
PNR
+$38.4M
2
VFC icon
VF Corp
VFC
+$38.2M
3
SHW icon
Sherwin-Williams
SHW
+$37.3M
4
SWK icon
Stanley Black & Decker
SWK
+$35.4M
5
AOS icon
A.O. Smith
AOS
+$35.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1B
2
MSFT icon
Microsoft
MSFT
+$833M
3
AMZN icon
Amazon
AMZN
+$495M
4
TSLA icon
Tesla
TSLA
+$313M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$295M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 11.57%
3 Consumer Staples 11.2%
4 Healthcare 10.36%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBIV
1776
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$17K ﹤0.01%
722
-456
-39% -$15.5K
SPIR icon
1777
Spire Global
SPIR
$425M
$16K ﹤0.01%
+1,756
New +$22.5K
DOMA
1778
DELISTED
Doma Holdings, Inc.
DOMA
$16K ﹤0.01%
+615
New +$26.1K
PRTY
1779
DELISTED
Party City Holdco Inc.
PRTY
$16K ﹤0.01%
12,251
-8,471
-41% -$18.7K
RNAC icon
1780
Cartesian Therapeutics
RNAC
$232M
$15K ﹤0.01%
394
-584
-60% -$17.3K
CARM
1781
DELISTED
Carisma Therapeutics
CARM
$13K ﹤0.01%
777
-2,142
-73% -$24.5K
OTLK icon
1782
Outlook Therapeutics
OTLK
$263M
$13K ﹤0.01%
665
-403
-38% -$11.6K
BODI icon
1783
The Beachbody Company
BODI
$78.9M
$13K ﹤0.01%
+235
New +$19K
AUD
1784
DELISTED
Audacy, Inc.
AUD
$13K ﹤0.01%
13,410
-8,710
-39% -$17.5K
SPPI
1785
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$11K ﹤0.01%
14,025
-33,513
-70% -$29.5K
BBLN
1786
DELISTED
Babylon Holdings Limited
BBLN
$11K ﹤0.01%
+489
New +$21.3K
BRDS
1787
DELISTED
Bird Global, Inc.
BRDS
$8K ﹤0.01%
+770
New +$23.5K
AKBA icon
1788
Akebia Therapeutics
AKBA
$327M
$5K ﹤0.01%
14,293
-36,514
-72% -$15.3K
ACEL icon
1789
Accel Entertainment
ACEL
$979M
-10,562
Closed -$129K
ADTN icon
1790
Adtran
ADTN
$798M
-11,170
Closed -$207K
ADUS icon
1791
Addus HomeCare
ADUS
$2.14B
-3,441
Closed -$322K
ADV icon
1792
Advantage Solutions
ADV
$484M
-573
Closed -$92K
ADVM
1793
DELISTED
Adverum Biotechnologies
ADVM
-2,644
Closed -$34K
AHCO icon
1794
AdaptHealth
AHCO
$1.46B
-13,442
Closed -$216K
AHRT
1795
AH Realty Trust
AHRT
$534M
-14,850
Closed -$217K
AIR icon
1796
AAR Corp
AIR
$5.15B
-7,539
Closed -$365K
ALGM icon
1797
Allegro MicroSystems
ALGM
$8.58B
-9,377
Closed -$267K
ALHC icon
1798
Alignment Healthcare
ALHC
$4.02B
-14,878
Closed -$168K
ALLK
1799
DELISTED
Allakos
ALLK
-12,273
Closed -$70K
ALT icon
1800
Altimmune
ALT
$539M
-11,650
Closed -$71K

Similar funds

ProShare Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, ProShare Advisors held 2,286 positions worth $30.2B, down 35% from $46.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

ProShare Advisors withdrew a net $9.03B in Q2 2022, closing 496 positions and reducing 1,551 holdings. Its most notable exit was People's United Financial Inc, an estimated $163M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, ProShare Advisors opened a new position in Peoples Bancorp worth $8.14M.

  • ProShare Advisors's largest Q2 2022 buy was Peoples Bancorp: 305,862 shares worth $8.14M.
  • ProShare Advisors added most to Pentair in Q2 2022, an estimated $38.4M increase.
  • ProShare Advisors's biggest Q2 2022 reduction was Apple, cutting an estimated $1B.
  • ProShare Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $163M.
  • ProShare Advisors's ten largest holdings make up 25% of its $30.2B portfolio in Q2 2022.
  • ProShare Advisors opened 90 new positions and closed 496 in Q2 2022.
  • ProShare Advisors's portfolio value fell 35% quarter-over-quarter to $30.2B.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.